
The tragic termination of the Diabetes Prevention Program Outcomes Study
An invaluable resource is being starved to death with no scientific or ethical justification

The use of placebo controls in clinical trials
Why the value of placebo controls is not an affirmation of a powerful placebo effect

Indiscriminate, Cruel, and Wasteful: Abandoning USAID clinical trials
The chaos and cruelty of its abrupt deconstruction are self-evident and already demonstrable

Botulinum Toxin: A tale of medicine, beauty, and danger
When used responsibly botulinum toxin is very safe, but patients should be especially vigilant about cosmetic treatments done outside a medical setting.

Pegcetacoplan (Syfovre™) for macular degeneration: an update
SBM's guest contributor and ophthalmologist, Dr. David Weinberg, provides an update on the phase 3 trials of pegcetacoplan for macular degeneration. The results are still disappointing.

Pegcetacoplan, a new treatment for macular degeneration
FDA approves a new treatment for macular degeneration: the good, the bad, and the disappointing.

The Stem Cell Ophthalmology Treatment Study (SCOTS): Part 2
Today we continue an analysis of a dubious stem cell clinical trial, with an examination of the clinic and personnel involved.

The Stem Cell Ophthalmology Treatment Study
In this study we have 300 patients with 47 different diseases subject to 7 experimental treatments among 3 treatment groups and no control group. What could possibly go right?

Hydroxychloroquine, retinal toxicity, and COVID-19
Hydroxychloroquine is being promoted as a treatment or prevention for COVID-19 based on questionable evidence. The long-term impact of hydroxychloroquine on the retina introduces another reason to be cautious about its use outside of clinical trials.
We are not antivaccine, we are pro unattainable vaccine
When it comes to vaccines: “If it exists we resist.”